子痫前期的规范化筛查与预防OA
Standardized screening and prevention of preeclampsia
子痫前期(preeclampsia,PE)作为妊娠期特有的严重并发症,病理机制复杂,迄今尚无针对病因的有效治疗手段,规范化筛查与精准预防是改善母儿结局的关键.然而,临床常将"规范化"误读为"全面化",导致低危人群陷入高成本检测与药物泛用的过度医疗,增加风险且稀释医疗资源.文章整合国内外指南与循证证据,梳理规范化筛查路径与分层预防方案,强调PE的精准防控在于严格界定干预边界,避免无指征的过度筛查与预防,确保医疗资源真正惠及高危人群.
Preeclampsia(PE)is a severe pregnancy-specif-ic complication with complex pathological mechanisms,and no etiological treatment is currently available.Therefore,standardized screening and precision prevention are critical to improving maternal and neonatal outcomes.However,in clinical practice,standardization is frequently misinterpret-ed as comprehensiveness,leading to overtreatment of costly testing in low-risk populations and overuse of drugs that in-crease risks and strain healthcare resources.This article in-tegrates domestic and international guidelines and evi-dence-based data to review a standardized screening path-way and stratified prevention strategy,emphasizing that the cornerstone of precise prevention and control of PE lies in strictly defining intervention boundaries and avoiding over-screening and unnecessary prevention without clear indica-tions,thus ensuring that medical resources are genuinely di-rected toward high-risk populations.
朱嘉钰;陈玉影;黄莉萍
南方医科大学南方医院妇产科,广东 广州 510515南方医科大学南方医院妇产科,广东 广州 510515南方医科大学南方医院妇产科,广东 广州 510515
医药卫生
子痫前期规范化筛查精准预防过度医疗
preeclampsiastandardized screeningprecise preventionovertreatment
《中国实用妇科与产科杂志》 2026 (8)
792-796,5
国家自然科学基金-区域联合重点项目(U24A206663)国家自然科学基金面上项目(82371690) Regional Joint Key Poject of Naional Natural Science Foundation of China(U24A206663)National Natural Science Foundation of China-General Program(82371690)
评论